Mechanisms of Smoothened Activation in Hedgehog Signaling
Hedgehog 信号传导平滑激活机制
基本信息
- 批准号:10552682
- 负责人:
- 金额:$ 32.3万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2022
- 资助国家:美国
- 起止时间:2022-02-01 至 2025-11-30
- 项目状态:未结题
- 来源:
- 关键词:AdultBasal cell carcinomaBindingBinding SitesBiochemicalBiochemistryBiophysicsBrainCellsChildhoodCholesterolCommunicationComplexCryoelectron MicroscopyDataDevelopmentErinaceidaeExtracellular DomainFoundationsGenetic TranscriptionHumanIn VitroIntegral Membrane ProteinLinkLipid BindingLipidsMalignant NeoplasmsMass Spectrum AnalysisMembraneModelingMolecularMolecular ConformationMutagenesisNMR SpectroscopyOrganismPathway interactionsPatternPharmaceutical PreparationsPhysiologicalPredispositionPublishingRegenerative MedicineRegulationRepressionResearchResistanceResolutionSignal PathwaySignal TransductionSignal Transduction PathwaySiteSkin CarcinomaSterolsStructureTherapeuticTissuesTransmembrane DomainUrochordataX-Ray Crystallographyantagonistbody systemdesignhedgehog signal transductioninhibitorinsightmedulloblastomamolecular dynamicsnanobodiesprogramsresistance mechanismsmoothened signaling pathwaystructural biologytumor
项目摘要
PROJECT SUMMARY/ABSTRACT
MECHANISMS OF SMOOTHENED ACTIVATION IN HEDGEHOG SIGNALING. The Hedgehog (Hh) signaling
pathway coordinates development in humans and most metazoans. In adult tissues, aberrant Hh pathway
activation drives various cancers, including basal cell carcinoma of the skin and pediatric brain
medulloblastoma. An unusual mechanism enables Hh signal transduction. In the basal state, the transporter-
like molecule Patched1 (PTCH1) represses Smoothened (SMO), a seven-transmembrane protein. Hh inhibits
PTCH1, which unleashes SMO activity causing downstream transcription. A leading mechanistic hypothesis is
that cellular sterols activate SMO, but are sequestered by PTCH1 in the absence of Hh. Connecting the
putative transport function of PTCH1 to SMO activation remains one of the central mysteries in understanding
how the Hh signal is transduced across the membrane. A critical gap is how, and which, sterols directly
influence SMO activation. This proposal will address these questions in two aims. The first aim focuses on
which sterols activate SMO. Here, we will combine biochemistry, structural biology, and signaling studies to
define which sterols can activate SMO and how they do so. In the second aim, we focus on how sterol binding
to distinct sites on SMO influences Hh pathway activity. We will use X-ray crystallography, cryo-electron
microscopy, and NMR spectroscopy to generate an integrated high-resolution perspective on where sterols
bind to SMO, and how they influence SMO activity. These studies will provide a mechanistic picture on how the
Hh signal is transduced across the membrane. Such insights may enable the design of SMO inhibitors less
susceptible to tumor resistance or Hh pathway modulators for regenerative medicine.
项目摘要/摘要
刺猬信号的平滑激活机制。刺猬(HH)信号
途径协调人类和大多数后生动物的发育。在成人组织中,异常的HH途径
激活会导致多种癌症,包括皮肤基底细胞癌和儿童脑癌
髓母细胞瘤。一种不寻常的机制使HH信号转导成为可能。在基本状态下,转运体-
与Patched1(Ptch1)分子一样,ptch1抑制七跨膜蛋白Smoothens(SMO)。HH抑制
Ptch1,释放SMO活性,导致下游转录。一个主要的机械论假说是
细胞甾醇激活SMO,但在没有HH的情况下被ptch1隔离。连接
Ptch1到SMO激活的运输功能仍然是理解的中心谜团之一。
HH信号是如何通过细胞膜传递的。一个关键的差距是如何以及哪种甾醇直接
影响SMO的激活。这项提案将从两个方面解决这些问题。第一个目标集中在
哪种甾醇能激活SMO。在这里,我们将结合生物化学、结构生物学和信号研究来
确定哪些甾醇可以激活SMO,以及它们是如何激活SMO的。在第二个目标中,我们将重点放在如何结合甾醇
SMO上不同的位置会影响HH途径的活性。我们将使用X射线结晶学,低温电子
显微镜和核磁共振光谱学,以生成关于甾醇在哪里的综合高分辨率透视
绑定到SMO,以及它们如何影响SMO活动。这些研究将提供一幅机械图景,说明
HH信号通过细胞膜进行传递。这种见解可能会使SMO抑制剂的设计变得更少
对肿瘤耐药或再生医学中的HH途径调节剂敏感。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Aashish Manglik其他文献
Aashish Manglik的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Aashish Manglik', 18)}}的其他基金
Mechanisms of Smoothened Activation in Hedgehog Signaling
Hedgehog 信号传导平滑激活机制
- 批准号:
10365068 - 财政年份:2022
- 资助金额:
$ 32.3万 - 项目类别:
Enhancing olfactory receptor expression for biochemical studies of odorant-receptor interactions
增强嗅觉受体表达以进行气味受体相互作用的生化研究
- 批准号:
10580041 - 财政年份:2022
- 资助金额:
$ 32.3万 - 项目类别:
Enhancing olfactory receptor expression for biochemical studies of odorant-receptor interactions
增强嗅觉受体表达以进行气味受体相互作用的生化研究
- 批准号:
10465009 - 财政年份:2022
- 资助金额:
$ 32.3万 - 项目类别:
Precision pharmacology by local control of opioid receptors in neural circuits
通过局部控制神经回路中的阿片受体实现精准药理学
- 批准号:
10219227 - 财政年份:2020
- 资助金额:
$ 32.3万 - 项目类别:
Precision pharmacology by local control of opioid receptors in neural circuits
通过局部控制神经回路中的阿片受体实现精准药理学
- 批准号:
10405103 - 财政年份:2020
- 资助金额:
$ 32.3万 - 项目类别:
Biochemical approaches to enlighten GPR85 function
生化方法揭示 GPR85 功能
- 批准号:
10047548 - 财政年份:2020
- 资助金额:
$ 32.3万 - 项目类别:
Precision pharmacology by local control of opioid receptors in neural circuits
通过局部控制神经回路中的阿片受体实现精准药理学
- 批准号:
10044383 - 财政年份:2020
- 资助金额:
$ 32.3万 - 项目类别:
相似海外基金
Precision oncology to define basal cell carcinoma (BCC) with high-risk histopathological subtypes
精准肿瘤学定义具有高风险组织病理学亚型的基底细胞癌 (BCC)
- 批准号:
485125 - 财政年份:2023
- 资助金额:
$ 32.3万 - 项目类别:
Operating Grants
Analysis of intraoperative videos from basal cell carcinoma removal surgery
基底细胞癌切除手术术中视频分析
- 批准号:
574060-2022 - 财政年份:2022
- 资助金额:
$ 32.3万 - 项目类别:
University Undergraduate Student Research Awards
Developing Improved Models of Basal Cell Carcinoma to Evaluate Tumor-Drug Response
开发改进的基底细胞癌模型以评估肿瘤药物反应
- 批准号:
10518702 - 财政年份:2022
- 资助金额:
$ 32.3万 - 项目类别:
Optimization of topical formulations for the treatment of basal cell carcinoma using the Feldan Shuttle technology
使用 Feldan Shuttle 技术优化治疗基底细胞癌的局部制剂
- 批准号:
549971-2020 - 财政年份:2022
- 资助金额:
$ 32.3万 - 项目类别:
Applied Research and Development Grants - Level 3
Predicting drug response for basal cell carcinoma by comprehensive genomic analysis.
通过综合基因组分析预测基底细胞癌的药物反应。
- 批准号:
21K16898 - 财政年份:2021
- 资助金额:
$ 32.3万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Optimization of topical formulations for the treatment of basal cell carcinoma using the Feldan Shuttle technology
使用 Feldan Shuttle 技术优化治疗基底细胞癌的局部制剂
- 批准号:
549971-2020 - 财政年份:2021
- 资助金额:
$ 32.3万 - 项目类别:
Applied Research and Development Grants - Level 3
Characterizing Genetic Factors that Modulate Stage-Specific Basal Cell Carcinoma Tumorigenesis
表征调节阶段特异性基底细胞癌肿瘤发生的遗传因素
- 批准号:
10066547 - 财政年份:2020
- 资助金额:
$ 32.3万 - 项目类别:
Optimization of topical formulations for the treatment of basal cell carcinoma using the Feldan Shuttle technology
使用 Feldan Shuttle 技术优化治疗基底细胞癌的局部制剂
- 批准号:
549971-2020 - 财政年份:2020
- 资助金额:
$ 32.3万 - 项目类别:
Applied Research and Development Grants - Level 3
Characterizing Genetic Factors that Modulate Stage-Specific Basal Cell Carcinoma Tumorigenesis
表征调节阶段特异性基底细胞癌肿瘤发生的遗传因素
- 批准号:
10212968 - 财政年份:2020
- 资助金额:
$ 32.3万 - 项目类别:
Characterizing Genetic Factors that Modulate Stage-Specific Basal Cell Carcinoma Tumorigenesis
表征调节阶段特异性基底细胞癌肿瘤发生的遗传因素
- 批准号:
10430040 - 财政年份:2020
- 资助金额:
$ 32.3万 - 项目类别: